Stocks and Investing Stocks and Investing
Mon, March 14, 2022
Fri, March 11, 2022

Jason Butler Maintained (VRDN) at Buy with Decreased Target to $31 on, Mar 11th, 2022


Published on 2024-10-27 20:03:54 - WOPRAI, Jason Butler
  Print publication without navigation


Jason Butler of JMP Securities, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $36 to $31 on, Mar 11th, 2022.

Jason has made no other calls on VRDN in the last 4 months.



There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Jason's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jason


  • Thomas Smith of "SVB Leerink" Initiated at Buy and Held Target at $32 on, Thursday, November 18th, 2021

Contributing Sources